This opportunity is no longer accepting applications.
grant NOT-AI-24-007

Notice of Special Interest (NOSI): RNA Delivery Technologies to Allow Specific Tissue Target Homing (RNA-DASH)

This grant opportunity supports research focused on testing and evaluating non-viral methods for delivering RNA-based therapies or vaccines directly to cells and tissues in the body. The goal is to improve delivery techniques, target specific organs, and overcome barriers both outside and inside cells.

The NOSI will support the pre-clinical testing and evaluation of non-viral technologies to deliver RNA-based therapeutics or RNA-based vaccines to disease-relevant somatic cells and tissues in vivo. This initiative aims to address challenges associated with RNA molecule delivery, including effic…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Allergy and Infectious Diseases

Eligibility

Small Businesses

Dates

Opportunity Released: February 2, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.